SEARCH

SEARCH BY CITATION

References

  • Bartik, M.M., Welker, D. & Kay, N.E. (1998) Impairments in immune cell function in B cell chronic lymphocytic leukemia. Seminars in Oncology, 25, 2733.
  • Buschle, M., Campana, D., Carding, S.R., Richard, C., Hoffbrand, A.V. & Brenner, M.K. (1993) Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 177, 213218.
  • Byrd, J.C., Shinn, C., Waselenko, J.K., Fuchs, E.J., Lehman, T.A., Nguyen, P.L., Flinn, I.W., Diehl, L.F., Sausville, E. & Grever, M.R. (1998) Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of Bcl-2 modulation or dependence on functional p53. Blood, 92, 38043816.
  • Chaouchi, N., Wallon, C., Taieb, J., Auffredou, M.T., Tertian, G., Lemoine, F.M., Delfraissy, J.F. & Vazquez, A. (1994) Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of Bcl-2 and c-myc. Clinical Immunology Immunopathology, 73, 197204.
  • Chaouchi, N., Wallon, C., Goujard, C., Tertian, G., Rudent, A., Caput, D., Ferrera, P., Minty, A., Vazquez, A. & Delfraissy, J.F. (1996) Interluekin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood, 87, 10221029.
  • Collins, R.J., Verschuer, L.A., Harmon, B.V., Prentice, R.L., Pope, J.H. & Kerr, J.F. (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. British Journal of Haematology, 71, 343350.
  • Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. & Sarfati, M. (1992) Interleukin-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and up-regulates Bcl-2 expression. Journal of Experimental Medicine, 176, 13191326.
  • De Totero, D., Reato, G., Mauro, F., Cignetti, A., Ferrini, S., Guarini, A., Gobbi, M., Grossi, C.E. & Foa, R. (1999) IL-4 production and increased CD30 expression by a unique CD8+ T cell subset in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 104, 589599.
  • Douglas, R.S., Capocasale, R.J., Lamb, R.J., Nowell, P.C. & Moore, J.S. (1997) Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood, 89, 941947,.
  • Fluckiger, A.C., Garrone, P., Durand, I., Galizzi, J.P. & Banchereau, J. (1993) Interluekin-10 (IL-10) up-regulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. Journal of Experimental Medicine, 178, 14731481.
  • Fluckiger, A.C., Durand, I. & Banchereau, J. (1994) Interleukin-10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. Journal of Experimental Medicine, 179, 9199.
  • Frankfurt, O.S., Byrnes, J.J. & Villa, L. (1997) Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients. Leukemia Research, 21, 916.DOI: 10.1016/s0145-2126(96)00053-7
  • Gajewski, F.T., Pinnas, M., Wong, T. & Fitch, F.W. (1991) Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen–presenting cell populations. Journal of Immunology., 146, 17501758.
  • Hersh, M.R., Kuhn, J.G., Philipp, J.L., Clark, G., Ludden, T.M. & Von Hoff, D.D. (1986) Pharmacokinetic study of fludarabine phosphate (NSC 312887). Cancer Chemotherapy Pharmacology, 17, 277280.
  • Huang, P. & Plunkett, W. (1991) Action of 9-beta-d-arabinofuranosyl-2 fluoroadenine on RNA metabolism. Molecular Pharmacology, 39, 449455.
  • Huang, S.K., Xiao, H.Q., Kleine-Tebbe, J., Paciotti, G., Marsh, D.V., Lichtenstein, L.M. & Liu, M.C. (1995) IL-13 expression at the sites of allergen challenge in patients with asthma. Journal of Immunology, 155, 26882694.
  • Jewell, A.P. (1996) Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia. Leukemia and Lymphoma, 21, 4348.
  • Jewell, A.P., Worman, C.P., Lydyard, P.M., Yong, K.L., Giles, F.J. & Goldstone, A.H. (1994) Interferon-alpha up-regulates Bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. British Journal of Haematology, 88, 268274.
  • Jurlander, J. (1998) The cellular biology of B-cell chronic lymphocytic leukemia. Critical Review Oncology Hematology, 27, 2952.
  • Kaminski, A., Demaine, A. & Prentice, A. (1998) Cytoplasmic interleukin-4 (IL-4) and surface IL-4 receptor expression in patients with B-cell lymphocytic leukemia. Blood, 92, 21882189.
  • Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H.G., Zhang, X., Bullrich, F., Croce, C.M., Rai, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood, 91, 33793389.
  • Maggi, E., Giudizi, M.G., Biagiotti, R., Annunziato, F., Manetti, R., Piccinni, M.P., Parronchi, P. & Sampognaro, S. & Giannarini, L. (1994) Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. Journal of Experimental Medicine, 180, 489495.
  • Mainou-Fowler, T. & Prentice, A.G. (1996) Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia. Leukemia and Lymphoma, 21, 369378.
  • Mainou-Fowler, T., Craig, V.A., Copplestone, J.A., Hamon, M.D. & Prentice, A.G. (1994) Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of Bcl-2 expression and is inhibited by IL-4. Blood, 84, 22972304.
  • Mainou-Fowler, T., Craig, V.A., Copplestone, A.J., Hamon, M.D. & Prentice, A.G. (1995) Effect of anti-APO1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: the role of Bcl-2 and interleukin-4. Leukemia and Lymphoma, 19, 301308.
  • Maliszewski, C.R., Sato, T.A., Vanden Bos, T., Waugh, S., Dower, S.K., Slack, J., Beckmann, M.P. & Grabstein, K.H. (1990) Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1 and IL-4-induced B cell activity in vitro. Journal of Immunology, 144, 30283033.
  • Mentz, F., Mossalayi, M.D., Ouaaz, F., Baudet, S., Issaly, F., Ktorza, S., Semichon, M., Binet, J.L. & Merle-Beral, H. (1996) Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood, 88, 21722182.
  • Mu, X., Kay, N.E., Gosland, M.P. & Jennings, C.D. (1997) Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence of increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells. British Journal of Haematology, 96, 733735.
  • Osorio, L.M., Jondal, M. & Aguilar-Santelises, M. (1998) Regulation of B-CLL apoptosis through membrane receptors and Bcl-2 family proteins. Leukemia and Lymphoma, 30, 247256.
  • Panayiotidis, P., Ganeshaguru, K., Jabbar, S.A. & Hoffbrand, A.V. (1993) Interleukin-4 inhibits apoptotic cell death and loss of the Bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology, 85, 439445.
  • Pepper, C., Hoy, T. & Bentley, D.P. (1997) Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. British Journal of Cancer, 76, 935938.
  • Pepper, C., Hoy, T. & Bentley, P. (1998) Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance. Leukemia and Lymphoma, 28, 355362.
  • Pepper, C., Thomas, A., Hoy, T. & Bentley, P. (1999) Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones. British Journal of Haematology, 104, 581588.
  • Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A. & Bottomly, K. (1995) Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. Journal of Experimental Medicine, 181, 15691574.
  • Pistoia, V. (1997) Production of cytokines by human B cells in health and disease. Immunology Today, 18, 343350.DOI: 10.1016/s0167-5699(97)01080-3
  • Plate, J.M.D., Knospe, W.H., Harris, J. & Gregory, S. (1993) Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias. Human Immunology, 36, 249258.
  • Prince, H.E., Bermudez, S. & Plaeger-Marshall, S. (1993) Preparation of CD8bright and CD8dim lymphocyte populations using two positive selection methods in tandem. Journal of Immunology Methods, 165, 139148.
  • Pu, Q.Q. & Bezwoda, W.R. (1997) Interleukin-4 prevents spontaneous in vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity. British Journal of Haematology, 98, 413417.
  • Reed, J.C. (1998) Molecular biology of chronic lymphocytic leukemia: implications for therapy. Seminars in Hematology, 35, 313.
  • Salgame, P., Abrams, J.S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R.L. & Bloom, B.R. (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science, 254, 279282.
  • Salgame, P., Yamamura, M., Bloom, B.R. & Modlin, R.L. (1992) Evidence for functional subsets of CD4+ and CD8+ T cells in human disease: lymphokine patterns in leprosy. Chemical Immunology, 54, 4459.
  • Secrist, H., DeKruyff, R.H. & Umetsu, D.T. (1995) Interleukin-4 production by CD4+ T cells from allergic individuals is modulated by antigen concentrations and antigen-presenting cell type. Journal of Experimental Medicine, 181, 10811089.
  • Seder, R.A. & Le Gros, G.G. (1995) The functional role of CD8+ T helper type 2 cells. Journal of Experimental Medicine, 181, 57.
  • Seder, R.A., Paul, W.E., Davis, M.M. & Fazekas de St Groth, B. (1992) The presence of interleukin-4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. Journal of Experimental Medicine, 176, 10911098.
  • Thomas, A., El Rouby, S., Reed, J.C., Krajewski, S., Silber, R., Potmesil, M. & Newcomb, E.W. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and Bcl-2/Bax proteins in drug resistance. Oncogene, 12, 10551063.